Literature DB >> 1730928

A transgenic model of autoimmune hemolytic anemia.

M Okamoto1, M Murakami, A Shimizu, S Ozaki, T Tsubata, S Kumagai, T Honjo.   

Abstract

We made double transgenic mice bearing immunoglobulin heavy and light chain genes encoding an autoantibody against the mouse erythrocyte by the cross of C57BL/6 mice carrying the transgene for each chain of the immunoglobulin. Although no obvious disorders were found in the single-chain transgenic mice, severely anemic symptoms were found in some of the double transgenic mice, in which most B cells express, at least on their surface, the autoantibody reactive to self-antigens on the erythrocyte. Individual double-transgenic mice showed a wide variation of phenotypes between severe anemia and no symptoms. Both deletion and anergy of autoreactive B cells were seen in each individual mouse, but their relative contribution to self-tolerance was variable and not directly related to the severity of anemia or the amount of the autoantibody produced. This transgenic system provides a good autoimmune disease model for exploring its onset mechanism, and means of its treatment and prevention.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730928      PMCID: PMC2119080          DOI: 10.1084/jem.175.1.71

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

Review 1.  Tolerance to self-antigens in transgenic mice.

Authors:  T E Adams
Journal:  Mol Biol Med       Date:  1990-08

2.  A monoclonal antibody against Igh6-4 determinant.

Authors:  S Nishikawa; Y Sasaki; T Kina; T Amagai; Y Katsura
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes.

Authors:  D A Nemazee; K Bürki
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

4.  In vivo generation and function of B cells in the presence of a monoclonal anti-IgM antibody: implications for B cell tolerance.

Authors:  A Gause; N Yoshida; C Kappen; K Rajewsky
Journal:  Eur J Immunol       Date:  1987-07       Impact factor: 5.532

5.  Monoclonal anti-erythrocyte autoantibodies derived from NZB mice cause autoimmune hemolytic anemia by two distinct pathogenic mechanisms.

Authors:  T Shibata; T Berney; L Reininger; Y Chicheportiche; S Ozaki; T Shirai; S Izui
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

6.  Production of sterile transcripts of C gamma genes in an IgM-producing human neoplastic B cell line that switches to IgG-producing cells.

Authors:  P Sideras; T R Mizuta; H Kanamori; N Suzuki; M Okamoto; K Kuze; H Ohno; S Doi; S Fukuhara; M S Hassan
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

7.  Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice.

Authors:  J Erikson; M Z Radic; S A Camper; R R Hardy; C Carmack; M Weigert
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

8.  Characterization of the enhancer region for germline transcription of the gamma 3 constant region gene of human immunoglobulin.

Authors:  K Kuze; A Shimizu; T Honjo
Journal:  Int Immunol       Date:  1991-07       Impact factor: 4.823

9.  Organization of the constant-region gene family of the mouse immunoglobulin heavy chain.

Authors:  A Shimizu; N Takahashi; Y Yaoita; T Honjo
Journal:  Cell       Date:  1982-03       Impact factor: 41.582

10.  Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

Authors:  M S Neuberger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  60 in total

1.  B cell clonal elimination induced by membrane-bound self-antigen may require repeated antigen encounter or cell competition.

Authors:  J Lang; D Nemazee
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

Review 2.  Maintenance and loss of self-tolerance in B cells.

Authors:  A Iglesias
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 3.  The regulation and activation potential of autoreactive B cells.

Authors:  Michele L Fields; Su-Jean Seo; Simone A Nish; Jeff H Tsai; Andrew J Caton; Jan Erikson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.

Authors:  Athenia L Oldham; Cathrine A Miner; Hong-Cheng Wang; Carol F Webb
Journal:  Mol Immunol       Date:  2011-10-02       Impact factor: 4.407

Review 5.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

Review 6.  Antigen-specific responses in autoimmunity and tolerance.

Authors:  J W Thomas
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

7.  Regulation of B-1 cell activation and its autoantibody production by Lyn kinase-regulated signallings.

Authors:  H Ochi; H Takeshita; T Suda; S Nisitani; T Honjo; T Watanabe
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

Review 8.  Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.

Authors:  S Giannouli; M Voulgarelis; P D Ziakas; A G Tzioufas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

9.  Increasing the chemical potential of the germ-line antibody repertoire.

Authors:  N Sarvetnick; D Gurushanthaiah; N Han; J Prudent; P Schultz; R Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

10.  Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg).

Authors:  T Vassilev; C Gelin; S V Kaveri; M T Zilber; L Boumsell; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.